Lead sponsor
Chase Pharmaceuticals Corporation, an affiliate of Allergan plc
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
0
Ongoing
90
Total enrollment
10
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
4
Trials by status
Completed
3
Withdrawn
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type DementiaAlzheimer's diseasePh 2Completed41